
Key strategies for accelerating development and manufacturing and development timelines to bring drugs to market faster and give developers a competitive advantage.
Key strategies for accelerating development and manufacturing and development timelines to bring drugs to market faster and give developers a competitive advantage.
Now supplying cleanroom doors, panels and accessories for all cleanroom applications.
The first of its kind prefabricated cleanroom system that integrates with the host facility floor.
Implementing automation involves careful optimization and fine-tuning of various parameters to ensure the accurate execution of cell-based potency assays.
G-CON Clean Solutions has a best in class offering of cleanroom doors, panels and accessories for all cleanroom applications.
A step-by-step path to building confidence in packaging component selection for injectable drugs
Ensure the success of clinical biomanufacturing programs by focusing on key tech transfer practices from the sponsor, commercial, scientific, and program management stakeholders.
Partnering with a CDMO with collective insights and capabilities to support the development and manufacture of an innovative biotherapeutic program is an essential first step to providing better care to patients.
As pipettes touch virtually every experiment, they influence the accuracy and repeatability of the experimental data.
This application note presents a protocol for Sf9 insect cell culture in stirred-tank bioreactors and recombinant protein production via a baculovirus vector system.
Discover how ReciBioPharm’s strategic approach helped to support the rapid delivery of an innovative oncolytic adenovirus therapy for advanced cancer to clinic.
Leveraging digital transformation and preparing for the lab of the future, LabVantage Solutions has devised a five-step process to successfully implement AI in the lab.
Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays, and how they overcome central challenges in biomarker assessment and ligand binding assays (LBAs).
This article explores process modeling and compares process economics between a conventional upstream process and three perfused seed train alternatives
This white paper provides an overview on an enabling cell retention solution resulting in greater cell-mass to achieve significantly higher titers.
In this white paper, we discuss seed train intensification strategies to leverage productivity increases and drive down costs.
Discover the benefits of using next generation processes and options to consider towards your path to upstream success.
We explore seed train intensification approaches which deliver significant upstream process improvements in speed, flexibility and reliability.
Learn a seed train intensification strategy for increasing productivity and biomass using perfusion technology.
Learn about the approaches used in upstream intensification to shorten the seed train workflow, improve reproducibility, and reduce the risk of contamination.
Achieve greater upstream productivity with intensified processing via a perfused seed train.
Earlier assessment of molecules provides valuable insights into the manufacturing developability of molecules, reducing the need for unnecessary experimentation. The Intabio ZT system has the potential to make in-depth characterization of biopharmaceutical product charge variants quicker and more efficient to meet demanding timelines during early-phase clinical development.
This article describes how to achieve optimal separation of oligonucleotides and related impurities by utilizing a dedicated method development software package based on AQbD.